on 26 Jun 2024
Last Applicant/ Owned by
Maxion Therapeutics Limited
C/O Mishcon de Reya, Africa House, 70 Kingsway
London, , WC2B 6AH
Serial Number
UK00004068314 filed on 26th Jun 2024
Registration Number
UK00004068314 registered on
27th Sept 2024
Correspondent Information
Stratagem Intellectual Property Management Limited
Meridian Court, Comberton Road, Toft
Cambridge,
CB23 2RY
Chemicals for use in industry and science; biochemicals, including polypeptides and antibodies for scientific, laboratory or research purposes; polypeptides and antibodies for use in the manufacture of pharmaceuticals and drugs; ion channel blocking antibodies for scientific, laboratory or research purposes; ion channel blocking antibodies for use in the manufacture of pharmaceuticals and drugs; antibodies derived from mini-protein toxins for scientific, laboratory or research purposes; antibodies derived from mini-protein toxins for use in the manufacture of pharmaceuticals and drugs.
Pharmaceuticals and pharmaceutical preparations; drugs; antibodies for medical use; pharmaceuticals, drugs and pharmaceutical preparations incorporating antibodies, ion channel blocking antibodies or antibodies derived from mini-protein toxins; vaccines.
Scientific and technological services and research and design relating thereto; drug discovery and drug development services; conducting or providing research and development services for others in the field of antibodies; laboratory services relating to the production of antibodies, ion channel blocking antibodies or antibodies derived from mini-protein toxins; antibody engineering; scientific services relating to the discovery, preclinical and clinical development of therapeutic products; information, advisory and consultancy services in relation to all of the aforesaid; .
Medical services; medical testing, analysis and diagnostic services in the field of antibodies; medical services connected with the treatment of diseases through the use of antibodies, ion channel blocking antibodies or antibodies derived from mini-protein toxins, or pharmaceuticals, drugs and pharmaceutical preparations derived from the aforesaid; information, advisory and consultancy services in relation to all of the aforesaid.
UK00004068314
Word
Individual